LABU holdings

All 173 positions of Direxion Daily S&P Biotech Bull 3X ETF.

Download CSV

Positions

173

Top 10 weight

248.9%

Effective holdings

10.4

1 / sum of squared weights

In stocks

77.7%

In bonds

0.0%

Outside the US

0.0%

Asset mix

Derivative247.7%
Equity77.7%

Sectors

100% of stocks classified

Health Care77.2%
Financials0.5%

Countries

United States74.9%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	SPSIBI SWAP ASSET LEG	Derivative	51.79%	$309M	26,459
2	SPSIBI SWAP ASSET LEG	Derivative	50.34%	$301M	25,717
3	SPSIBI SWAP ASSET LEG	Derivative	45.85%	$274M	23,421
4	SPSIBI SWAP ASSET LEG	Derivative	36.41%	$217M	18,598
5	SPSIBI SWAP ASSET LEG	Derivative	30.86%	$184M	15,766
6	GOLDMAN FINL SQ TRSRY INST 506	Derivative	21.66%	$129M	129,338,200	US
7	SPSIBI SWAP ASSET LEG	Derivative	4.17%	$25M	2,129
8	DREYFUS GOVT CASH MAN INS	Derivative	3.39%	$20M	20,251,996
9	SPSIBI SWAP ASSET LEG	Derivative	2.72%	$16M	1,388
10	MRNAModerna, Inc. Common Stock	Equity	1.72%	$10M	52,007	US
11	TWSTTwist Bioscience Corporation Common Stock	Equity	1.43%	$8.5M	56,188	US
12	NTRANatera, Inc. Common Stock	Equity	1.40%	$8.3M	21,351	US
13	ABBVABBVIE INC.	Equity	1.28%	$7.7M	28,109	US
14	UTHRUnited Therapeutics Corp	Equity	1.24%	$7.4M	13,914	US
15	AMGNAmgen Inc	Equity	1.23%	$7.3M	18,025	US
16	BIIBBiogen Inc. Common Stock	Equity	1.22%	$7.3M	33,469	US
17	HALOHalozyme Therapeutics, Inc.	Equity	1.21%	$7.2M	65,672	US
18	IOVAIovance Biotherapeutics, Inc. Common Stock	Equity	1.20%	$7.1M	536,955	US
19	EXELExelixis Inc	Equity	1.20%	$7.1M	120,908	US
20	GILDGilead Sciences Inc	Equity	1.19%	$7.1M	48,422	US
21	TGTXTG Therapeutics, Inc.	Equity	1.15%	$6.9M	129,049	US
22	VRTXVertex Pharmaceuticals Inc	Equity	1.14%	$6.8M	13,533	US
23	PTGXProtagonist Therapeutics, Inc	Equity	1.13%	$6.8M	48,376	US
24	KRYSKrystal Biotech, Inc. Common Stock	Equity	1.11%	$6.6M	20,260	US
25	CRSPCRISPR Therapeutics AG	Equity	1.10%	$6.5M	129,647	US
26	PTCTPTC Therapeutics, Inc.	Equity	1.09%	$6.5M	104,374	US
27	SYRESpyre Therapeutics, Inc. Common Stock	Equity	1.09%	$6.5M	81,131	US
28	REGNRegeneron Pharmaceuticals Inc	Equity	1.08%	$6.5M	8,730	US
29	NBIXNeurocrine Biosciences Inc	Equity	1.08%	$6.4M	45,460	US
30	RVMDRevolution Medicines, Inc. Common Stock	Equity	1.07%	$6.4M	33,961	US
31	INCYIncyte Genomics Inc	Equity	1.06%	$6.3M	55,971	US
32	ALKSAlkermes Inc. plc	Equity	1.04%	$6.2M	155,347
33	GRALGRAIL, Inc. Common Stock	Equity	1.04%	$6.2M	46,931	US
34	ERASErasca, Inc. Common Stock	Equity	1.04%	$6.2M	399,997	US
35	PCVXVaxcyte, Inc. Common Stock	Equity	1.03%	$6.2M	94,994	US
36	MDGLMadrigal Pharmaceuticals, Inc. Common Stock	Equity	1.03%	$6.2M	12,901	US
37	ALNYAlnylam Pharmaceuticals, Inc.	Equity	1.03%	$6.1M	27,337	US
38	BBIOBridgeBio Pharma, Inc. Common Stock	Equity	1.01%	$6.0M	92,702	US
39	BMRNBioMarin Pharmaceuticals Inc	Equity	1.01%	$6.0M	109,495	US
40	ORKAOruka Therapeutics, Inc. Common Stock	Equity	1.00%	$6.0M	77,080	US
41	CYTKCytokinetics Inc.	Equity	0.99%	$5.9M	95,164	US
42	KODKodiak Sciences Inc Common Stock	Equity	0.97%	$5.8M	61,427	US
43	ROIVRoivant Sciences Ltd. Common Shares	Equity	0.97%	$5.8M	168,684
44	COGTCogent Biosciences, Inc. Common Stock	Equity	0.94%	$5.6M	186,176	US
45	KYMRKymera Therapeutics, Inc. Common Stock	Equity	0.93%	$5.6M	51,073	US
46	TVTXTravere Therapeutics, Inc. Common Stock	Equity	0.93%	$5.5M	106,505	US
47	IBRXImmunityBio, Inc. Common Stock	Equity	0.93%	$5.5M	558,482	US
48	INSMInsmed, Inc.	Equity	0.92%	$5.5M	54,757	US
49	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	0.91%	$5.5M	125,895	US
50	DNTHDianthus Therapeutics, Inc. Common Stock	Equity	0.91%	$5.4M	65,886	US
51	PRAXPraxis Precision Medicines, Inc. Common Stock	Equity	0.90%	$5.4M	20,427	US
52	ARWRArrowhead Research Corporation	Equity	0.87%	$5.2M	85,355	US
53	RYTMRhythm Pharmaceuticals, Inc. Common Stock	Equity	0.85%	$5.1M	56,527	US
54	VCYTVeracyte, Inc.	Equity	0.81%	$4.9M	111,296	US
55	MIRMMirum Pharmaceuticals, Inc. Common Stock	Equity	0.80%	$4.8M	58,656	US
56	CGONCG Oncology, Inc. Common stock	Equity	0.78%	$4.7M	73,578	US
57	VKTXViking Therapeutics, Inc	Equity	0.76%	$4.6M	164,404	US
58	TNGXTango Therapeutics, Inc.	Equity	0.73%	$4.4M	194,008	US
59	RLAYRelay Therapeutics, Inc. Common Stock	Equity	0.68%	$4.0M	232,086	US
60	BEAMBeam Therapeutics Inc. Common Stock	Equity	0.68%	$4.0M	164,233	US
61	CDNACareDx, Inc.	Equity	0.66%	$3.9M	63,307	US
62	CELCCelcuity Inc. Common Stock	Equity	0.65%	$3.9M	57,133	US
63	RAREUltragenyx Pharmaceutical Inc.	Equity	0.63%	$3.7M	244,182	US
64	SRRKScholar Rock Holding Corporation Common Stock	Equity	0.61%	$3.7M	87,008	US
65	ARQTArcutis Biotherapeutics, Inc. Common Stock	Equity	0.59%	$3.5M	144,722	US
66	DYNDyne Therapeutics, Inc. Common Stock	Equity	0.57%	$3.4M	208,423	US
67	PURRHyperliquid Strategies Inc Common Stock	Equity	0.54%	$3.2M	287,131	US
68	RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	Equity	0.53%	$3.1M	795,950	US
69	SLSSELLAS Life Sciences Group, Inc. Common Stock	Equity	0.51%	$3.1M	271,502	US
70	IMVTImmunovant, Inc. Common Stock	Equity	0.51%	$3.1M	100,974	US
71	SMMTSummit Therapeutics Inc. Common Stock	Equity	0.50%	$3.0M	174,179	US
72	IDYAIDEAYA Biosciences, Inc. Common Stock	Equity	0.46%	$2.7M	76,026	US
73	BCRXBioCryst Pharmaceuticals Inc	Equity	0.46%	$2.7M	330,207	US
74	DNLIDenali Therapeutics Inc. Common Stock	Equity	0.46%	$2.7M	146,399	US
75	VERAVera Therapeutics, Inc. Class A Common Stock	Equity	0.44%	$2.6M	87,900	US
76	AGIOAgios Pharmaceuticals, Inc.	Equity	0.44%	$2.6M	81,634	US
77	NTLAIntellia Therapeutics, Inc	Equity	0.43%	$2.6M	205,397	US
78	SRPTSarepta Therapeutics,, Inc. Common Stock	Equity	0.43%	$2.6M	141,825	US
79	NVAXNovavax Inc	Equity	0.41%	$2.4M	220,598	US
80	RCUSArcus Biosciences, Inc.	Equity	0.40%	$2.4M	99,238	US
81	NRIXNurix Therapeutics, Inc. Common stock	Equity	0.39%	$2.3M	105,062	US
82	ACADAcadia Pharmaceuticals Inc.	Equity	0.39%	$2.3M	118,479	US
83	PVLAPalvella Therapeutics, Inc. Common Stock	Equity	0.38%	$2.3M	17,360	US
84	CLDXCelldex Therapeutics, Inc	Equity	0.38%	$2.3M	76,819	US
85	ADMAADMA Biologics, Inc.	Equity	0.38%	$2.2M	217,263	US
86	VRDNViridian Therapeutics, Inc. Common Stock	Equity	0.37%	$2.2M	119,573	US
87	QUREuniQure N.V.	Equity	0.37%	$2.2M	96,960
88	ABSIAbsci Corporation Common Stock	Equity	0.35%	$2.1M	237,021	US
89	VCELVericel Corporation	Equity	0.35%	$2.1M	52,876	US
90	BHVNBiohaven Ltd.	Equity	0.35%	$2.1M	177,265
91	IRONDisc Medicine, Inc. Common Stock	Equity	0.35%	$2.1M	34,488	US
92	PGENPrecigen, Inc. Common Stock	Equity	0.35%	$2.1M	271,882	US
93	SNDXSyndax Pharmaceuticals, Inc.	Equity	0.35%	$2.1M	122,062	US
94	NKTRNektar Therapeutics	Equity	0.32%	$1.9M	46,729	US
95	GOLDMAN SACHS FIN GOV 465 INSTITUT	Derivative	0.32%	$1.9M	1,891,640
96	IMNMImmunome, Inc.	Equity	0.30%	$1.8M	93,500	US
97	MLYSMineralys Therapeutics, Inc. Common Stock	Equity	0.26%	$1.6M	70,376	US
98	REPLReplimune Group, Inc.	Equity	0.26%	$1.6M	119,219	US
99	XNCRXencor, Inc.	Equity	0.26%	$1.5M	62,479	US
100	STOKStoke Therapeutics, Inc. Common Stock	Equity	0.25%	$1.5M	62,847	US
101	INBXInhibrx Biosciences, Inc. Common Stock	Equity	0.24%	$1.4M	15,563	US
102	ANABAnaptysBio, Inc. Common Stock	Equity	0.24%	$1.4M	30,686	US
103	ORICOric Pharmaceuticals, Inc. Common Stock	Equity	0.23%	$1.4M	115,847	US
104	VIRVir Biotechnology, Inc. Common Stock	Equity	0.23%	$1.4M	121,999	US
105	TRAXFirst Tracks Biotherapeutics, Inc. Ordinary Shares	Equity	0.22%	$1.3M	41,888	US
106	ZBIOZenas BioPharma, Inc. Common Stock	Equity	0.22%	$1.3M	49,721	US
107	KURAKura Oncology, Inc.	Equity	0.21%	$1.3M	121,780	US
108	MNKDMannkind Corporation	Equity	0.20%	$1.2M	343,378	US
109	JBIOJade Biosciences, Inc. Common Stock	Equity	0.19%	$1.2M	82,166	US
110	ARDXArdelyx, Inc.	Equity	0.19%	$1.1M	348,489	US
111	ANNXAnnexon, Inc. Common Stock	Equity	0.19%	$1.1M	280,202	US
112	RIGLRigel Pharmaceuticals Inc. (New)	Equity	0.19%	$1.1M	22,702	US
113	TYRATyra Biosciences, Inc. Common Stock	Equity	0.19%	$1.1M	55,339	US
114	TSHATaysha Gene Therapies, Inc. Common Stock	Equity	0.18%	$1.1M	246,242	US
115	GERNGeron Corp	Equity	0.18%	$1.1M	865,189	US
116	GLUEMonte Rosa Therapeutics, Inc. Common Stock	Equity	0.17%	$1.0M	100,835	US
117	CADLCandel Therapeutics, Inc. Common Stock	Equity	0.17%	$1.0M	104,436	US
118	JANXJanux Therapeutics, Inc. Common Stock	Equity	0.17%	$1.0M	54,356	US
119	VORVor Biopharma Inc. Common Stock	Equity	0.17%	$1.0M	52,305	US
120	AVTXAvalo Therapeutics, Inc. Common Stock	Equity	0.16%	$946K	70,469	US
121	IMMXImmix Biopharma, Inc. Common Stock	Equity	0.15%	$916K	98,584	US
122	CGEMCullinan Therapeutics, Inc. Common Stock	Equity	0.15%	$908K	58,762	US
123	BCAXBicara Therapeutics Inc. Common Stock	Equity	0.15%	$900K	52,163	US
124	CRVSCorvus Pharmaceuticals, Inc.	Equity	0.15%	$886K	86,808	US
125	VSTMVerastem, Inc.	Equity	0.15%	$873K	107,670	US
126	OLMAOlema Pharmaceuticals, Inc. Common Stock	Equity	0.13%	$804K	102,793	US
127	RGNXREGENXBIO Inc.	Equity	0.13%	$768K	94,930	US
128	COAGHemab Therapeutics Holdings, Inc. Common Stock	Equity	0.13%	$762K	24,672	US
129	AVBPArriVent BioPharma, Inc. Common Stock	Equity	0.12%	$736K	44,019	US
130	SVRASavara Inc.	Equity	0.12%	$735K	152,247	US
131	SANASana Biotechnology, Inc. Common Stock	Equity	0.12%	$730K	261,726	US
132	ACHVAchieve Life Sciences, Inc.	Equity	0.12%	$722K	100,418	US
133	FDMT4D Molecular Therapeutics, Inc. Common Stock	Equity	0.12%	$715K	56,297	US
134	DAMORA THERAPEUTICS INC	Derivative	0.12%	$713K	34,675
135	CAPRCapricor Therapeutics Inc	Equity	0.11%	$683K	85,269	US
136	ALLOAllogene Therapeutics, Inc. Common Stock	Equity	0.10%	$621K	443,610	US
137	PRMEPrime Medicine, Inc. Common Stock	Equity	0.10%	$621K	173,373	US
138	IRWDIronwood Pharmaceuticals, Inc. - Class A	Equity	0.10%	$616K	159,126	US
139	CTMXCytomX Therapeutics, Inc.	Equity	0.10%	$601K	243,269	US
140	KLRAKailera Therapeutics, Inc. Common Stock	Equity	0.10%	$586K	58,550	US
141	EDITEditas Medicine, Inc. Common Stock	Equity	0.10%	$576K	202,665	US
142	SLDBSolid Biosciences Inc. Common Stock	Equity	0.10%	$572K	83,852	US
143	MYGNMyriad Genetics Inc	Equity	0.10%	$570K	135,742	US
144	CLYMClimb Bio, Inc. Common Stock	Equity	0.09%	$560K	51,569	US
145	ABUSArbutus Biopharma Corporation Common Stock	Equity	0.09%	$559K	133,824
146	ALTAltimmune, Inc. Common Stock	Equity	0.09%	$554K	213,260	US
147	MNPRMonopar Therapeutics Inc. Common Stock	Equity	0.09%	$552K	6,578	US
148	SGMTSagimet Biosciences Inc. Series A Common Stock	Equity	0.09%	$540K	60,534	US
149	EBSEmergent Biosolutions, Inc.	Equity	0.09%	$527K	77,412	US
150	DSGNDesign Therapeutics, Inc. Common Stock	Equity	0.09%	$515K	44,784	US
151	OCGNOcugen, Inc. Common Stock	Equity	0.08%	$507K	518,941	US
152	STTKShattuck Labs, Inc. Common Stock	Equity	0.08%	$497K	87,799	US
153	SPRYARS Pharmaceuticals, Inc. Common Stock	Equity	0.08%	$475K	104,258	US
154	CABACabaletta Bio, Inc. Common Stock	Equity	0.08%	$462K	236,915	US
155	AKTSAktis Oncology, Inc. Common stock	Equity	0.07%	$433K	24,431	US
156	MDXGMiMedx Group, Inc	Equity	0.07%	$398K	86,225	US
157	VNDAVanda Pharmaceuticals Inc.	Equity	0.07%	$388K	85,710	US
158	PRTAProthena Corporation plc Ordinary Shares	Equity	0.06%	$373K	43,328
159	NGNENeurogene, Inc. Common Stock	Equity	0.06%	$339K	12,794	US
160	ASMBAssembly Biosciences, Inc	Equity	0.06%	$330K	14,458	US
161	OVIDOvid Therapeutics Inc. Common Stock	Equity	0.05%	$311K	133,001	US
162	AURAAura Biosciences, Inc. Common Stock	Equity	0.05%	$292K	44,952	US
163	FTHFaeth Therapeutics, Inc. Common Stock	Equity	0.04%	$263K	10,272	US
164	LXEOLexeo Therapeutics, Inc. Common Stock	Equity	0.04%	$243K	75,807	US
165	DREYFUS TRSRY SECURITIES CASH MGMT	Derivative	0.04%	$241K	240,950
166	CMPXCompass Therapeutics, Inc. Common Stock	Equity	0.04%	$227K	230,386	US
167	CBIOCrescent Biopharma, Inc. Common Stock	Equity	0.04%	$225K	15,933	US
168	BBOTBridgeBio Oncology Therapeutics, Inc. Common Stock	Equity	0.02%	$108K	31,551	US
169	INHIBRX INC CVR	Derivative	0.00%	$0	164,173	US
170	NOVOB DC CVR	Derivative	0.00%	$0	128,720
171	OMNIAB INC - 12.5 EARNOUT	Derivative	0.00%	$0	14,783
172	OMNIAB INC - 15.00 EARNOUT	Derivative	0.00%	$0	14,783
173	VERVE THERAPEUTICS INC (CVR)	Derivative	0.00%	$0	82,531

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Increase	APLSApellis Pharmaceuticals Inc	0.45%	1.53%	+29.4%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	FOLDAmicus Therapeutics Inc.	0.81%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	TVTXTravere Therapeutics Inc	0.61%	1.33%	+10.7%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	SYRESpyre Therapeutics Inc	0.20%	0.88%	+31.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	RNAMAvidity Biosciences Inc.	0.68%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	EXASExact Sciences Corporation	0.68%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	SMMTSummit Therapeutics Inc.	0.48%	1.15%	+10.6%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	APGEApogee Therapeutics Inc.	0.37%	1.04%	+52.7%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	ACLXArcellx Inc	0.55%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	MDGLMadrigal Pharmaceuticals Inc	0.59%	1.12%	+22.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	BEAMBeam Therapeutics Inc.	0.56%	1.09%	+20.2%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	RVMDRevolution Medicines Inc	0.83%	1.35%	−25.5%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ARWRARROWHEAD PHARMACEUTICALS INC	0.67%	1.18%	+13.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	KODKodiak Sciences Inc	0.16%	0.64%	+47.6%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	COGTCogent Biosciences Inc.	0.46%	0.93%	+38.3%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	KYMRKymera Therapeutics Inc	0.49%	0.93%	+15.9%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	CAPRCAPRICOR THERAPEUTICS INC	—	0.43%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ORKAOruka Therapeutics Inc	0.15%	0.57%	+29.3%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	IMNMImmunome Inc	0.32%	0.74%	+69.3%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	IRONDisc Medicine Inc	0.32%	0.74%	+83.4%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	RAREULTRAGENYX PHARMACEUTICAL INC	0.44%	0.85%	+29.4%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ERASErasca Inc	0.16%	0.56%	+136.3%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	NUVLNUVALENT INC	0.54%	0.94%	+20.6%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	RCUSArcus Biosciences Inc.	0.23%	0.61%	+52.3%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	BCRXBIOCRYST PHARMACEUTICALS INC	0.29%	0.67%	+13.8%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ARQTArcutis Biotherapeutics Inc.	0.50%	0.88%	+30.7%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	IMVTImmunovant Inc	0.40%	0.77%	+26.9%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	IBRXImmunityBio Inc	0.44%	0.80%	+10.4%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	NBIXNEUROCRINE BIOSCIENCES INC	0.59%	0.95%	+14.5%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	INSMInsmed Inc	0.55%	0.92%	+29.8%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	INBXInhibrx Biosciences Inc.	0.08%	0.42%	+125.8%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	NRIXNurix Therapeutics Inc.	0.17%	0.52%	+103.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ALNYALNYLAM PHARMACEUTICALS INC	0.56%	0.90%	+20.3%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	UTHRUnited Therapeutics Corporation	0.65%	0.98%	−15.2%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	VCYTVeracyte Inc	0.38%	0.71%	+48.3%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	DVAXDynavax Technologies Corp.	0.33%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	VERAVera Therapeutics Inc.	0.43%	0.75%	+45.7%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	NTRANatera Inc.	0.66%	0.98%	+13.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	CGONCG Oncology Inc.	0.64%	0.94%	−21.2%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ACADACADIA PHARMACEUTICALS INC	0.57%	0.85%	+12.6%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	CELCCelcuity Inc.	0.72%	0.98%	−16.2%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	OLMAOlema Pharmaceuticals Inc.	0.13%	0.39%	+259.1%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	AGIOAgios Pharmaceuticals Inc	0.34%	0.60%	+17.5%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	GLUEMonte Rosa Therapeutics Inc	0.16%	0.42%	+90.7%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	SLSSELLAS LIFE SCIENCES GROUP INC	—	0.26%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	BIIBBiogen Inc	0.68%	0.93%	−11.2%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	PVLAPalvella Therapeutics Inc.	0.14%	0.39%	+14.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	NTLAIntellia Therapeutics Inc	0.33%	0.56%	+14.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	RAPTRAPT Therapeutics Inc.	0.22%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	DNTHDianthus Therapeutics Inc	0.36%	0.57%	−33.7%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	DAWNDay One Biopharmaceuticals Inc.	0.20%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	PRAXPRAXIS PRECISION MEDICINES INC	0.80%	1.00%	−16.1%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	TYRATyra Biosciences Inc	0.05%	0.25%	+177.1%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	ZBIOZENAS BIOPHARMA INC	—	0.19%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	RYTMRhythm Pharmaceuticals Inc	0.66%	0.85%	+10.9%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ARDXArdelyx Inc	0.35%	0.54%	+28.5%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	ROIVRoivant Sciences Ltd	0.72%	0.90%	−34.8%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	KRYSKrystal Biotech Inc	0.78%	0.96%	−10.4%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ABSIAbsci Corp.	0.07%	0.25%	+44.6%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	RXRXRECURSION PHARMACEUTICALS INC	0.47%	0.64%	+13.0%	Jan 31, 2026 → Apr 30, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.